I Hate Dialysis Message Board

Dialysis Discussion => Dialysis: Medical Breakthroughs => Topic started by: Cordelia on November 11, 2011, 12:11:55 PM

Title: Article about Possible Breakthrough in the Future.........
Post by: Cordelia on November 11, 2011, 12:11:55 PM
http://www.dailymail.co.uk/health/article-2046418/Kidney-breakthrough-free-transplant-patients-lifetime-anti-rejection-drugs.html
Title: Re: Article about Possible Breakthrough in the Future.........
Post by: MooseMom on November 11, 2011, 12:59:13 PM
I think this is the protocol followed by cariad at Northwestern.

Notice that this applies only to recipients who are lucky enough to have a living donor.  There aren't enough living donors...  They need to start working on better ways to prevent rejection in patients who have cadaveric kidneys. 
Title: Re: Article about Possible Breakthrough in the Future.........
Post by: Cordelia on November 11, 2011, 01:41:16 PM
I agree!    :thumbup;     :)
Title: Re: Article about Possible Breakthrough in the Future.........
Post by: Joe on November 11, 2011, 02:06:21 PM
I agree with both of you, but one step at a time
Title: Re: Article about Possible Breakthrough in the Future.........
Post by: cariad on November 11, 2011, 03:26:23 PM
This is an article about the Stanford protocol. It is slightly different and seems to have only been used on six-antigen matched kidneys from relatives. This is not exactly news if you've been following this field at all, but I imagine Stanford is sending out press info like everywhere else.

http://www.clinicaltrials.gov/ct2/show/NCT00801632?term=tolerance+kidney+transplant&rank=8 (http://www.clinicaltrials.gov/ct2/show/NCT00801632?term=tolerance+kidney+transplant&rank=8)
This is a trial at Mass General where I originally tried to get my transplant performed. They are enrolling participants who are awaiting a cadaver transplant. I know it says 'suspended' but if anyone is interested, I would call them. This has been posted up at clinicaltrials.gov for well over a year, and my surgeon has said that they expect to open a variation of their trial up to cadaver organ recipients within a year or two.